Scientists identify genes linked to specific diseases
Statistical methodology developed by University of Queensland (UQ) researchers is using what is said to be the largest set of multilevel genomic data ever compiled to help scientists pinpoint the genes within our DNA that are linked to specific diseases.
The number of disease-associated DNA markers identified by genome-wide association studies (GWAS) is growing fast, but mapping disease genes has been difficult due to the complicated structure of the genome.
“While we already knew a number of genomic regions that are associated with certain diseases, until now we’ve lacked the ability to narrow down exactly where the causative changes occur and which genes are affected by the changes,” said UQ researcher Professor Jian Yang, who won a 2017 Prime Minister’s Prize for Science for his work analysing the human genome.
“Identifying these genes and their functional regulators is critical to understanding how to prevent, diagnose and treat complex diseases such as Crohn’s disease, rheumatoid arthritis and coronary heart disease.”
Professor Yang and his research team used an innovative method to unlock the complexities behind genome-wide DNA markers, gene activity and DNA methylation — chemical modifications of DNA that regulate how genes behave. The results were published in the journal Nature Communications.
“By unlocking this information, we’re able to prioritise the genes mostly likely to be responsible for 12 complex diseases,” he said.
“For example, we found that a change that occurs in the regulatory DNA of one particular gene (ATG16L1) alters its DNA methylation status, which explains its association with Crohn’s disease.”
Professor Yang said the study serves as a significant leap forward in research around some of the world’s biggest health issues, with its findings allowing for focused follow-up studies to accelerate the development of targeted clinical trials and drug treatments.
“Gathering greater insights around how genes link to disease will help drive innovation in medical and pharmaceutical research, as well as shaping public health policy,” he said.
“Increasingly, the future of medicine will be data driven and personalised. Using technology to create more value from the data we have is critical to developing more effective approaches to our biggest health issues.”
A pre-emptive approach to treating leukaemia relapse
The monitoring of measurable residual disease (MRD), medication and low-dose chemotherapy is...
Long COVID abnormalities appear to resolve over time
Researchers at UNSW's Kirby Institute have shown that biomarkers in long COVID patients have...
RNA-targeted therapy shows promise for childhood dementia
Scientists have shown that a new RNA-targeted therapy can halt the progression of a specific type...
